Quest Diagnostics, Inc. (NYSE:DGX)
| CAPS Rating |
|
|---|---|
| Open | $57.50 |
| Previous Close | $57.71 |
| Daily Range | $56.66 - $57.57 |
| 52-Week Range | $45.13 - $61.47 |
| Market Cap | $9.11B |
| P/E Ratio | 17.20 |
| Dividend (Yield) | 0.68 (0.70%) |
| Volume | 1,028,482 |
| Average Daily Volume | 0 |
DGX
VS S&P 500 (SPY)
How do you think DGX will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
DGX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
DGX News and Commentary
- LabCorp Beats on EPS, Revs Miss - Analyst Blog – NASDAQ
- Earning Scorecard: Quest Diagnostics - Analyst Blog – NASDAQ
- Do You Trust the Earnings at Quest Diagnostics? – The Motley Fool
- Does Quest Diagnostics Measure Up? – The Motley Fool
- Is Quest Diagnostics' Buyback Good for Investors? – The Motley Fool
- This Blockbuster Drug Just Got Better – The Motley Fool
- DaVita Acquires Stake in Indian Co. - Analyst Blog – NASDAQ
- Has Sequenom Become the Perfect Stock? – The Motley Fool
- Quest or Labcorp – How About a Smaller Option? – Blogs @ The Motley Fool
- 1 Reason the Street Should Love Quest Diagnostics' Earnings – The Motley Fool
- Companies Investing Right Along With You – The Motley Fool
- Quest Diagnostics Beats Up on Analysts Yet Again – The Motley Fool
- Quest's EPS Beats, Revs In Line - Analyst Blog – NASDAQ
- US STOCK FUTURES: HOT STOCKS TO WATCH – SmartMoney
- US STOCK FUTURES: HOT STOCKS TO WATCH -2- – SmartMoney
- 50% of This Market Would Be Just Fine – The Motley Fool
- Stocks on the Road to Greatness – The Motley Fool
- Biogen Preserves MS Drug's Sales With Label Change – Minyanville
- FDA Nod for Quest's STRATIFY JCV - Analyst Blog – NASDAQ
- Earnings Preview: Quest Diagnostics - Analyst Blog – NASDAQ
RSS Headlines
Fool UK
